The Pharmaceutical Journal
Vol 274 No 7349 p575
14 May 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Anagrelide approved for use within NHS Wales

The Welsh minister for health and social services has endorsed the use of anagrelide (Xagrid) within NHS Wales following the All Wales Medicines Strategy Group’s recommendations. This will be subject to the formation of a standard protocol for the management of patients with thrombocythaemia in Wales.

Anagrelide failed to gain approval for use in NHS Scotland this month.